NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 1 filers reported holding NUVATION BIO INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $56,734 | -17.7% | 42,238 | +10.4% | 0.00% | – |
Q2 2023 | $68,971 | -84.2% | 38,257 | -85.5% | 0.00% | – |
Q1 2023 | $437,787 | +75250.6% | 263,743 | -12.9% | 0.00% | – |
Q4 2022 | $581 | -99.9% | 302,868 | -2.2% | 0.00% | – |
Q3 2022 | $694,000 | +298.9% | 309,678 | +476.9% | 0.00% | – |
Q2 2022 | $174,000 | – | 53,683 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 22,957,340 | $195,137,000 | 27.59% |
Aisling Capital Management LP | 2,541,009 | $21,599,000 | 7.62% |
EDBI Pte Ltd | 1,270,504 | $10,799,000 | 5.87% |
EcoR1 Capital, LLC | 13,896,543 | $118,121,000 | 3.76% |
Ally Bridge Group (NY) LLC | 1,197,152 | $10,176,000 | 3.56% |
Boxer Capital, LLC | 4,341,009 | $36,899,000 | 1.43% |
Avidity Partners Management LP | 7,382,488 | $62,751,000 | 1.33% |
Baupost Group | 8,623,021 | $72,957,000 | 0.72% |
Abrams Capital Management | 3,811,513 | $32,398,000 | 0.71% |
Redmile Group, LLC | 3,671,009 | $31,204,000 | 0.71% |